Beijing Science Sun Pharmaceutical Co., Ltd. (SHE:300485)
China · Delayed Price · Currency is CNY 8.57
-0.23 (-2.61%)
Jul 30, 2026, 12:14 PM CST
SHE:300485 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 402.62 | 404.72 | 416.48 | 476.57 | 734.55 | 1,051 |
Revenue Growth | 0.78% | -2.82% | -12.61% | -35.12% | -30.10% | -3.97% |
Gross Profit Gross Profit Growth | 261.15 | 257.13 | 273.26 | 335.63 | 562.94 | 868.68 |
Operating Income Operating Income Growth | -8.49 | -17.25 | 22.44 | -39.75 | 24.24 | 95.41 |
Net Income Net Income Growth | -20.74 | 14.57 | -68.85 | 102.92 | 204.73 | 402.27 |
Earnings Per Share EPS Growth | -0.04 | 0.03 | -0.14 | 0.21 | 0.43 | 0.84 |
EPS Growth | - | - | - | -51.16% | -48.81% | 162.50% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Medicine Manufacturing Medicine Manufacturing Growth | 396.22 | 398.32 | 414.95 | 475.92 | 733.73 | 1,050 |
Unallocated Other Operations Unallocated Other Operations Growth | - | 6.4 | 1.53 | 0.65 | 0.82 | 1.15 |
Total Total Growth | 402.62 | 404.72 | 416.48 | 476.57 | 734.55 | 1,051 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 1,621 | 1,562 | 1,572 | 1,174 | 1,122 | 1,296 |
Total Debt Total Debt Growth | 19.68 | 19.86 | - | - | - | - |
Net Cash (Debt) Net Cash Growth | 1,601 | 1,542 | 1,572 | 1,174 | 1,122 | 1,296 |
Net Cash Growth | -0.24% | -1.87% | 33.92% | 4.63% | -13.47% | 9.82% |
Net Cash Per Share Net Cash Per Share Growth | 3.30 | 3.18 | 3.20 | 2.39 | 2.36 | 2.71 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 27.35 | 27.08 | 135.97 | 21.21 | 110.43 | 183.3 |
Capital Expenditures CapEx Growth | -99.43 | -100.28 | -101.13 | -52.91 | -43.28 | -45.91 |
Free Cash Flow Free Cash Flow Growth | -72.09 | -73.2 | 34.85 | -31.7 | 67.15 | 137.38 |
Free Cash Flow Growth | - | - | - | - | -51.12% | -5.83% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 64.86% | 63.53% | 65.61% | 70.43% | 76.64% | 82.67% |
Operating Margin | -2.11% | -4.26% | 5.39% | -8.34% | 3.30% | 9.08% |
Pretax Margin | -7.64% | 3.04% | -20.06% | 25.63% | 34.66% | 41.78% |
Profit Margin | -5.15% | 3.60% | -16.53% | 21.60% | 27.87% | 38.28% |
FCF Margin | -17.90% | -18.09% | 8.37% | -6.65% | 9.14% | 13.07% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.300 | 0.300 | - | 0.022 | 0.086 | 0.168 |
Dividend Per Share Growth | 0% | - | - | -74.42% | -48.81% | 158.46% |
Dividend Yield | 3.39% | 2.84% | - | 0.21% | 0.73% | 1.31% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | 349.74 | - | 49.56 | 28.19 | 15.79 |
Forward PE | - | 27.14 | 27.14 | 27.14 | 27.14 | 27.14 |
P/FCF Ratio | - | - | 96.89 | - | 85.93 | 46.25 |
PS Ratio | 10.53 | 12.59 | 8.11 | 10.70 | 7.86 | 6.05 |